腹腔鏡輔助低位直腸癌保肛術(shù)與開(kāi)腹低位直腸癌保肛術(shù)療效的比較
本文選題:腹腔鏡輔助 + 開(kāi)腹。 參考:《大連醫(yī)科大學(xué)》2015年碩士論文
【摘要】:目的:本研究總結(jié)腹腔鏡輔助下低位直腸癌前切除保肛術(shù)與開(kāi)腹低位直腸癌前切除保肛術(shù)患者的臨床資料,進(jìn)行對(duì)比分析,探討腹腔鏡輔助下低位直腸癌前切除保肛術(shù)的安全性、微創(chuàng)性與優(yōu)越性。方法:總結(jié)大連醫(yī)科大學(xué)附屬第一醫(yī)院2009年1月至2014年9月施行腹腔鏡輔助下低位直腸癌前切除保肛術(shù)的33例病例與同期開(kāi)腹低位直腸癌前切除保肛術(shù)的39例病例的臨床資料,分為腹腔鏡組與開(kāi)腹組,對(duì)兩組的手術(shù)時(shí)間,術(shù)中出血量,術(shù)后恢復(fù)情況(術(shù)后排氣時(shí)間、術(shù)后排便時(shí)間、術(shù)后住院時(shí)間、給予止痛藥次數(shù)),術(shù)后并發(fā)癥發(fā)生率,術(shù)后病理(上下切緣、淋巴結(jié)清除數(shù)量),術(shù)后半年的肛門功能,術(shù)后局部復(fù)發(fā)率,遠(yuǎn)處轉(zhuǎn)移率,術(shù)后生存時(shí)間進(jìn)行對(duì)比。結(jié)果:72例患者均保留肛門,未行預(yù)防性回腸造瘺,均達(dá)到腫瘤根治性標(biāo)準(zhǔn),腹腔鏡組與開(kāi)腹組手術(shù)時(shí)間分別為229min和161min,術(shù)中出血量為36ml和57ml,差異均具有統(tǒng)計(jì)學(xué)意義;術(shù)后排氣時(shí)間分別為3天和4天,排便時(shí)間分別為9天和7天,術(shù)后平均住院時(shí)間分別為13天和18天,術(shù)后給予止痛藥次數(shù)平均為1.5次和2.7次,術(shù)后半年的Wexner便秘評(píng)分分別為13分和14分,這些數(shù)據(jù)均具有統(tǒng)計(jì)學(xué)差異;腹腔鏡組與開(kāi)腹組的上下切緣均為陰性,其下切緣平均長(zhǎng)度分別為3.5cm和2.9cm,有統(tǒng)計(jì)學(xué)差異;淋巴結(jié)清掃數(shù)量為16枚和13枚,無(wú)統(tǒng)計(jì)學(xué)差異。術(shù)后并發(fā)癥發(fā)生率腹腔鏡組與開(kāi)腹組分別為15.1%(5/33)和35.9%(14/39),腹腔鏡組明顯低于開(kāi)腹組,差異具有統(tǒng)計(jì)學(xué)意義,兩組的局部復(fù)發(fā)率分別為6.0%和7.7%,遠(yuǎn)處轉(zhuǎn)移率分別為9.1%和12.8%,差異無(wú)統(tǒng)計(jì)學(xué)意義;腹腔鏡組和開(kāi)腹組的平均生存時(shí)間為45.7個(gè)月和54.5個(gè)月,沒(méi)有統(tǒng)計(jì)學(xué)差異。結(jié)論:腹腔鏡低位直腸癌前切除保肛術(shù)較開(kāi)腹低位直腸癌前切除保肛術(shù)具有術(shù)中出血少,術(shù)后恢復(fù)快,術(shù)后并發(fā)癥少等優(yōu)勢(shì),肛門功能能得到更好的保護(hù),而在腫瘤切緣及淋巴結(jié)清掃數(shù)目方面,兩組沒(méi)有明顯差異,在局部復(fù)發(fā)率及遠(yuǎn)處轉(zhuǎn)移率、總的生存時(shí)間上也沒(méi)有顯著差異。腹腔鏡輔助低位直腸癌前切除保肛手術(shù)具有手術(shù)安全性,微創(chuàng)性及腫瘤安全性,但其長(zhǎng)期療效,仍有待大規(guī)模,多中心研究的報(bào)道。有條件的醫(yī)院對(duì)分期較早的低位直腸癌患者若切除足夠的遠(yuǎn)端切緣后仍可保留肛管和肛管括約肌以及肛提肌者,應(yīng)選擇腹腔鏡保肛手術(shù)進(jìn)行治療以提高患者生活質(zhì)量。
[Abstract]:Objective: to summarize the clinical data of patients with laparoscopic assisted anterior resection of low rectal cancer and open resection of low rectal cancer. To investigate the safety, minimally invasive and superiority of laparoscopic anterior resection of low rectal cancer. Methods: from January 2009 to September 2014, 33 patients with low rectal cancer underwent laparoscopically assisted anus preservation surgery and 39 patients with low rectal cancer who underwent anus preservation surgery at the same time, from January 2009 to September 2014 in the first affiliated Hospital of Dalian Medical University. The patients were divided into two groups: laparoscopic group and laparotomy group. The operative time, blood loss, postoperative recovery (postoperative exhaust time, postoperative defecation time, postoperative hospitalization time, number of times of analgesic administration, postoperative complications) were observed in the two groups. Postoperative pathology (upper and lower incised margin, lymph node clearance, anal function half a year after operation, local recurrence rate, distant metastasis rate, survival time after operation were compared. Results the anus was retained in all the 72 patients without prophylactic ileostomy. The operative time of laparoscopy group and laparotomy group were 229min and 161 min, respectively. The amount of bleeding during operation was 36ml and 57 ml, respectively. The difference was statistically significant. The postoperative exhaust time was 3 days and 4 days, defecation time was 9 days and 7 days, postoperative average hospitalization time was 13 days and 18 days, and the average number of times of postoperative analgesic administration was 1.5 and 2.7 times. The scores of Wexner constipation were 13 points and 14 points respectively in six months after operation, and there was statistical difference between the laparoscopic group and the laparotomy group in the upper and lower incisors, the average length of the lower incisor was 3.5cm and 2.9 cm, respectively, there was statistical difference between the laparoscopic group and the laparotomy group. The number of lymph node dissection was 16 and 13, there was no statistical difference. The incidence of postoperative complications in the laparoscopy group and the open group were 15.1g / 33) and 35.9B / 14 / 39, respectively. The incidence of postoperative complications in the laparoscopic group was significantly lower than that in the open group (P < 0.05), and the difference was statistically significant. The local recurrence rates of the two groups were 6.0% and 7.7%, the distant metastasis rates were 9.1% and 12.8%, respectively, and the average survival time of the laparoscopic group and the open group were 45.7 months and 54.5 months, respectively. Conclusion: laparoscopic anus preserving surgery for low rectal cancer has the advantages of less bleeding, faster recovery, less postoperative complications and better protection of anal function. However, there was no significant difference in the number of tumor margin and lymph node dissection between the two groups, and there was no significant difference in local recurrence rate, distant metastasis rate and total survival time between the two groups. Laparoscopic assisted anus preserving surgery for low rectal cancer is safe, minimally invasive and safe. However, the long-term efficacy of laparoscopically assisted anterior resection of low rectal cancer remains to be reported in large scale and multicenter studies. In order to improve the quality of life of patients with lower rectal cancer patients with lower rectal cancer in early stage who can retain anal canal anal sphincter and levator muscle after resection of enough distal margin laparoscopic anal preservation surgery should be selected to improve the quality of life.
【學(xué)位授予單位】:大連醫(yī)科大學(xué)
【學(xué)位級(jí)別】:碩士
【學(xué)位授予年份】:2015
【分類號(hào)】:R735.37
【相似文獻(xiàn)】
相關(guān)期刊論文 前10條
1 高成山;直腸癌保肛術(shù)后局部復(fù)發(fā)32例報(bào)告[J];中國(guó)基層醫(yī)藥;2003年09期
2 李宇飛;;低位直腸癌保肛術(shù)45例臨床分析[J];基層醫(yī)學(xué)論壇;2011年13期
3 張少偉;;低位直腸癌保肛術(shù)中直腸沖洗治療對(duì)預(yù)后的影響[J];中國(guó)實(shí)用醫(yī)藥;2011年33期
4 許發(fā)培;;直腸癌保肛術(shù)后復(fù)發(fā)原因及處理[J];中級(jí)醫(yī)刊;1993年01期
5 張偉健,,劉少華;中、低位直腸癌保肛術(shù)的可行性分析[J];廣州醫(yī)藥;1994年03期
6 邱新賢,丁天壽;自制管在低位直腸癌保肛術(shù)中的應(yīng)用[J];浙江腫瘤;1996年03期
7 令狐蘇;低位直腸癌保肛術(shù)30例療效評(píng)估[J];南通醫(yī)學(xué)院學(xué)報(bào);1998年03期
8 張立飛;直腸癌保肛術(shù)后復(fù)發(fā)的外科治療[J];華夏醫(yī)學(xué);2000年03期
9 謝慶偉;直腸癌保肛術(shù)的研究進(jìn)展[J];醫(yī)學(xué)文選;2000年05期
10 李世擁;直腸癌保肛術(shù)式的爭(zhēng)論[J];中國(guó)普外基礎(chǔ)與臨床雜志;2001年01期
相關(guān)會(huì)議論文 前8條
1 肖建安;王海學(xué);李保忠;;直腸癌保肛術(shù)后復(fù)發(fā)原因分析及防治[A];第六次全國(guó)大腸癌會(huì)議暨中日韓大腸癌會(huì)議論文匯編[C];1998年
2 周小娜;李五生;劉金龍;姚健;鐘開(kāi)倫;;降低直腸癌保肛術(shù)后局部復(fù)發(fā)的對(duì)策[A];中西醫(yī)結(jié)合大腸肛門病研究新進(jìn)展——第十屆中國(guó)中西醫(yī)結(jié)合學(xué)會(huì)大腸肛門病學(xué)術(shù)研討會(huì)論文集[C];2004年
3 崔q輝;;直腸癌保肛術(shù)及相關(guān)新進(jìn)展[A];2008年浙江省肛腸外科學(xué)術(shù)年會(huì)暨繼續(xù)教育培訓(xùn)班資料匯編[C];2008年
4 張東銘;林琳;;低位直腸癌保肛術(shù)的解剖生理學(xué)基礎(chǔ)[A];中華中醫(yī)藥學(xué)會(huì)第十二次大腸肛門病學(xué)術(shù)會(huì)議論文匯編[C];2006年
5 依杰;;低位直腸癌保肛術(shù)式護(hù)理體會(huì)[A];大腸肛門病論文匯編[C];2001年
6 張士銘;何瑾;薛春梅;;荷包鉗替代線型吻合器在直腸癌保肛術(shù)中的應(yīng)用[A];2013年浙江省肛腸外科學(xué)術(shù)年會(huì)暨結(jié)直腸疾病的微創(chuàng)及綜合治療新進(jìn)展學(xué)習(xí)班論文匯編[C];2013年
7 張華;季兵;吳東升;;低位直腸癌保肛術(shù)中螺紋管的應(yīng)用[A];中西醫(yī)結(jié)合肛腸病研究新進(jìn)展[C];2000年
8 龔航軍;薛志祥;李財(cái)寶;;直腸癌保肛術(shù)后局部復(fù)發(fā)的原因分析及預(yù)防[A];中國(guó)中西醫(yī)結(jié)合學(xué)會(huì)大腸肛門專業(yè)委員會(huì)第九次全國(guó)學(xué)術(shù)會(huì)議論文集[C];2003年
相關(guān)重要報(bào)紙文章 前1條
1 孫國(guó)根;直腸癌保肛術(shù)中腸管吻合將更加簡(jiǎn)便[N];中國(guó)醫(yī)藥報(bào);2009年
相關(guān)碩士學(xué)位論文 前7條
1 徐一石;加速康復(fù)在直腸癌保肛術(shù)中的應(yīng)用研究[D];第三軍醫(yī)大學(xué);2011年
2 唐錦;腹腔鏡輔助低位直腸癌保肛術(shù)與開(kāi)腹低位直腸癌保肛術(shù)療效的比較[D];大連醫(yī)科大學(xué);2015年
3 楊烈;距離肛緣3-5cm之間的直腸癌保肛術(shù):臨床效果及生存質(zhì)量評(píng)價(jià)[D];四川大學(xué);2004年
4 薛巍松;直腸癌保肛術(shù)后排便功能障礙研究[D];福建醫(yī)科大學(xué);2014年
5 楊帆;低位直腸癌保肛術(shù)諸因素分析及輔助治療意義探討[D];河北醫(yī)科大學(xué);2013年
6 胡建昆;微創(chuàng)化直腸癌保肛術(shù)患者圍手術(shù)期的免疫學(xué)變化[D];四川大學(xué);2002年
7 謝剛銀;PTEN和CD44v6基因在直腸癌保肛術(shù)中作為遠(yuǎn)切緣預(yù)測(cè)因子的研究[D];重慶醫(yī)科大學(xué);2007年
本文編號(hào):1799443
本文鏈接:http://sikaile.net/yixuelunwen/zlx/1799443.html